会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 30. 发明授权
    • Counteracting bioprosthetic calcification
    • 抵制生物假体钙化
    • US07156881B2
    • 2007-01-02
    • US10336857
    • 2003-01-06
    • Robert J. LevyIvan Alferiev
    • Robert J. LevyIvan Alferiev
    • A61F2/02
    • A61K31/663A61L27/3687A61L27/54A61L31/16A61L2400/02
    • Adapting crosslinking with triglycidyl amine (TGA) to incorporate the use of a particular type of anti-calcification agent provides a broad-reaching solution to the problem in vivo bioprosthesis calcification. The anti-calcification agent in question includes a polyphosphonate compound that contains a functional group, which serves as a reaction site between the polyphosphonate and a polyepoxide. The functional group is reactive enough to dominate the reaction between the polyphosphonate and the polyepoxide, thereby excluding the chelating oxygen atoms of polyphosphonate from the reaction, protecting their anti-calcification ability. Furthermore, the high reactivity of the functional group allows the polyphosphonate to attach to the polyepoxide more completely, which improves the calcification resistance of bioprosthetic material with which the polyepoxide is crosslinked.
    • 使用三缩水甘油胺(TGA)进行交联以引入特定类型的抗钙化剂的使用为体内生物假体钙化提供了广泛的解决方案。 所讨论的抗钙化剂包括含有官能团的聚膦酸酯化合物,其用作聚膦酸盐和聚环氧化物之间的反应位点。 官能团反应性足以支配聚膦酸酯与聚环氧化物之间的反应,从反应中排除多膦酸的螯合氧原子,保护其抗钙化能力。 此外,官能团的高反应性允许聚膦酸盐更加完全地附着到聚环氧化物上,这提高了聚环氧化物交联的生物纤维材料的耐钙性。